ClinConnect ClinConnect Logo
Search / Trial NCT06336226

Brachio Basilic Arterio Venous Fistula One Stage vs Two Stage

Launched by ASSIUT UNIVERSITY · Mar 22, 2024

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at two different surgical methods for creating a type of access point for dialysis called a brachiobasilic arteriovenous fistula (BBAVF). The study aims to compare the success rates of these two methods: a one-stage approach, where the fistula is created in one surgery, and a two-stage approach, where it is done in two separate surgeries. Researchers want to find out which method works better in terms of how well the fistula functions over time.

To participate in the trial, patients must have end-stage renal disease and meet specific criteria, such as having a certain size for their arteries and veins as measured by ultrasound. Participants need to be able to give their consent and commit to attending follow-up visits. This trial is not yet recruiting, so no patients are currently enrolled, but it aims to help improve the way dialysis access is created for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients with end-stage renal disease who had their BBAVFs created either by the one-stage or two- stage technique.
  • Patients with brachial artery diameter more than 3 . mm by duplex ultrasound (DUS).
  • Patients with triphasic brachial artery by DUS.
  • Patients with basilic vein diameter more than 3 mm by DUS.
  • Patients who were able to give informed consent.
  • Requirements for intervention agreement between the patient and the surgeon.
  • Availability of patients for all follow-up visits.
  • Exclusion Criteria:
  • Patients who already had a suitable cephalic vein for arteriovenous fistula creation.
  • Patients whose brachial artery diameter was less than 3 mm by DUS.
  • Patients with brachial artery disease proved by DUS.
  • Patients whose basilic vein diameter was less than mm by DUS.
  • Patients with ischemic cardiomyopathy.
  • Patients with central venous stenosis or occlusion evidenced by duplex scanning.
  • Patients with flexion deformity or skin lesions at the site of the fistula or over the course of the vein.

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

Patients applied

0 patients applied

Trial Officials

Haitham A Hasan, Professor

Study Chair

Assiut University

Ahmed Kh Sayed, Lecturer

Study Director

Assiut University

Wael A Abdelgawad, Lecturer

Principal Investigator

Al-Azhar University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported